France Ophthalmic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The france ophthalmic devices market size is projected to expand from USD 2.53 billion in 2025 and USD 2.71 billion in 2026 to USD 3.95 billion by 2030, registering a CAGR of 7.81% between 2026 to 2030. This report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).

France Ophthalmic Devices Market Trends and Insights

Aging Population & Rising Cataract Prevalence

Citizens aged 75 years and older will swell by 40% between 2025 and 2035, ensuring a sustained upswing in lens-extraction demand that already exceeds 850,000 procedures annually. Multifocal and extended-depth-of-focus lenses now account for 25% of private-clinic implants, tripling unit values compared with monofocal alternatives. Regional hot spots align with high-volume laser platforms, and Alcon’s international implantables revenue rose 9% currency in 2024 on the back of French premium-IOL adoption.

Technological Advances in Diagnostic Imaging

Swept-source OCT and OCT angiography achieve axial resolution below 5 µm, pushing early detection of macular edema, optic-nerve fiber loss, and micro-aneurysms past the limits of color fundus photography. The 5,000-patient EviRed study showed OCTA sensitivity above 92% for proliferative diabetic retinopathy, compared with 78% for fundus imaging. CNAM reimbursement codes granted in 2024 catalyzed private-clinic uptake, and EssilorLuxottica deepened the modality with its February 2025 acquisition of Cellview Imaging.

High Capital Cost of Advanced Surgical Platforms

Femtosecond lasers priced at USD 400,000-600,000 plus USD 40,000-60,000 annual service fees deter clinics performing fewer than 1,000 cataract cases a year. Pay-per-procedure leasing shifts margin pressure to manufacturers and slows next-generation R&D despite vendor initiatives that cut per-case fees to EUR 150-200.

Other drivers and restraints analyzed in the detailed report include:

• Expansion of Premium IOL Reimbursement Pathways
• Emergence of Tele-Ophthalmology Hubs
• Stringent EU MDR & ANSM Approval Timelines

Segment Analysis

Vision Care Devices accounted for 62.49% of the France ophthalmic devices market in 2025, underpinned by EssilorLuxottica’s 35-plant, 583-lab network which yielded roughly 550 million prescription lenses per year. The Diagnostic & Monitoring sub-category is forecast to outpace at an 8.17% CAGR, as OCT scanners, AI-ready fundus cameras, and remote-reading software equip community practices and tele-screening hubs. Heidelberg Engineering’s OCT line, now 80%-owned by EssilorLuxottica, anchors the surge. Surgical

Product-level differentiation hinges on bundled ecosystems: diagnostics feed surgical conversion, and vision-care chains cross-sell contact lenses and myopia-control spectacles. This closed-loop positioning allows vertical giants to defend margins, whereas standalone imaging firms pursue OEM alliances. Competitive spillover already sees vision-care cash-flows underwriting R&D for swept-source imaging, sustaining technology refreshes every 2-4 years.

Complete Report Scope:

• By Device Type
  • Diagnostic & Monitoring Devices
    • OCT Scanners
    • Fundus & Retinal Cameras
    • Autorefractors & Keratometers
    • Corneal Topography Systems
    • Ultrasound Imaging Systems
    • Perimeters & Tonometers
    • Other Diagnostic & Monitoring Devices
  • Surgical Devices
    • Cataract Surgical Devices
    • Vitreoretinal Surgical Devices
    • Refreactive Surgical Devices
    • Glaucoma Surgical Devices
    • Other Surgical Devices
  • Vision Care Devices
    • Spectacles Frames & Lenses
    • Contact Lenses
• By Disease Indication
  • Cataract
  • Glaucoma
  • Diabetic Retinopathy
  • Other Disease Indications
• By End-user
  • Hospitals
  • Specialty Ophthalmic Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Other End-users

List of Companies Covered in this Report:

• Alcon
• Bausch + Lomb Corporation
• Carl Zeiss
• CooperVision Inc.
• EssilorLuxottica
• Glaukos
• Heidelberg Engineering
• HOYA
• Johnson & Johnson
• Lensar Inc.
• Lumenis
• Nidek
• Topcon
• Ziemer Group

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support